Clinademi Research Private Limited

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-expanded-use-amgens-rare-disease-drug-2025-04-03/

US FDA approves Amgen's Uplizna as first treatment for rare immune disorder The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the regulator said on Thursday.

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-new-cagrisema-study-focus-dose-escalation-trial-length-2025-02-05/

Novo Nordisk defends next-gen obesity drug CagriSema, details new trial Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value.

https://fortune.com/2024/11/26/novo-nordisk-foundation-ceo-nokia-risk-denmark-economy/

Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ to Denmark’s economy Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion people living with obesity.

https://www.moneycontrol.com/news/business/markets/astrazeneca-pharma-shares-in-focus-on-cdsco-permission-12828086.html

AstraZeneca Pharma shares jump 12% to 52-week high on CDSCO permission AstraZeneca Pharma India Share Price Today | The company has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion (Imfinzi).

https://fortune.com/europe/2024/09/23/novo-nordisk-nokia-risk-mette-frederiksen-denmark/

Novo Nordisk's market value of $570 billion is more than Denmark's annual GDP But Danish prime minister Mette Frederiksen isn't worried about a 'Nokia risk' from pharma giant.

https://medicaldialogues.in/amp/news/industry/pharma/drug-alert-48-drug-samples-fail-to-clear-cdsco-test-1-declared-spurious-114770

48 Drug Samples Including Alkem's PAN 40, Cadila's ACILOC 150 Fail To Qualify CDSCO Test, 1 Declared spurious New Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 48 medicine batches for failing to qualify for a random...

https://m.timesofindia.com/city/delhi/delhi-hc-orders-meet-on-clinical-trials-for-therapies-on-rare-diseases/articleshow/98553571.cms

Delhi HC orders meet on clinical trials for therapies on rare diseases | Delhi News - Times of India Delhi high court has directed National Consortium for Rare Diseases to hold a meeting on clinical trials for developing indigenous therapies for D***e

https://m.timesofindia.com/business/india-business/us-health-regulator-puts-on-hold-sun-pharma-trials-on-dermatological-drug/articleshow/99933458.cms

US health regulator puts on hold Sun Pharma trials on dermatological drug - Times of India India Business News: NEW DELHI: The US health regulator has directed Sun Pharma to stop trials of a dermatological drug with a 12 mg dose regimen as its usage could lead t.

https://www.thehindu.com/sci-tech/health/cdsco-suspends-manufacturing-of-eye-drops-linked-to-adverse-events-in-us/article66471515.ece

Central Drugs Standard Control Organisation bars Tamil Nadu-based firm from making eye lubricant NEW DELHI

https://studycafe.in/cdsco-recruitment-2023-monthly-salary-up-to-45000-check-posts-eligibility-and-how-to-apply-217683.html

CDSCO Recruitment 2023: Monthly Salary up to 45000, Check Posts, Eligibility and How to Apply CDSCO invites applications from eligible candidates for the post of TDA(Admn./Fin.) in CDSCO (Headquarters). There are 3 vacancies.